RE
Runwal Enterprises IPO — Grey Market Premium (GMP) Today
NSE + BSE · Mainboard IPO · GMP Tracker
Upcoming
📋 Mainboard
NSE + BSE
—
GMP Today
₹305
Issue Price
₹305(0%)
Est. Listing
RE Runwal Enterprises Limited IPO Real Estate Developer Residential & Commercial Spaces Integrated Townships Mumbai Mainline IPO Fresh Issue Only NSE, BSE 305 Upper Price 500. The issue price for Runwal Enterprises IPO is ₹305. GMP tracking will begin soon and is updated daily on this page. Runwal Enterprises is scheduled to list on 05 October 2026. We update GMP every day — bookmark this page to track the latest trend. Note: GMP data is collected from grey market participants for informational purposes only. ForgeUp does not trade in or recommend grey market transactions.
🔍
Data Source: GMP data is collected from grey market dealers and cross-verified across multiple sources before publishing. ForgeUp publishes this for informational purposes only. Rates may vary and are updated daily.
Grey Market Premium — Awaited
📊
GMP Not Started Yet
Grey market premium for Runwal Enterprises IPO will appear here once tracking begins.
We update daily — bookmark this page.
We update daily — bookmark this page.
Updates start with tracking ✓ Verified Daily
What happened to IPOs like this one
The closest matches from 134 past IPOs we have tracked to listing, ranked mainly on how heavily each was applied for. Of these 6, the typical listing was +18% and 1 listed below the issue price.
| IPO | Applied for | Issue | Listed at |
|---|---|---|---|
| Tempsens Instruments IPO Main | 184.22x | ₹300 | +111.3% |
| GSP Crop Science Limited IPO Main | 1.64x | ₹320 | +2.5% |
| Behari Lal Engineering IPO Main | 118.07x | ₹285 | +63.2% |
| Manipal Payment & Identity Solutions IPO Main | 1.42x | ₹339 | -2.7% |
| Sunshine Pictures IPO Main | 105.81x | ₹360 | +10% |
| Karamtara Engineering IPO Main | 62.63x | ₹254 | +26% |
These are counts of what happened before, not a forecast. A handful of past IPOs cannot tell you what this one will do, which is why the number of matches is shown rather than hidden.
Frequently Asked Questions
What is Runwal Enterprises IPO GMP today?▾
No grey market price has been quoted for Runwal Enterprises IPO yet. This page updates hourly, so check back.
What is the expected listing price of Runwal Enterprises IPO?▾
Going by the current grey market premium, Runwal Enterprises IPO would list near ₹305 against an issue price of ₹305. GMP is a sentiment indicator, not a promise — see our published accuracy record.
What is the lot size and minimum investment for Runwal Enterprises IPO?▾
One lot of Runwal Enterprises IPO is 49 shares. At the ₹305 issue price that is about ₹14,945 for a single retail application.
When does Runwal Enterprises IPO close and list?▾
Bidding closes on 29 September 2026 and the shares are expected to list on 05 October 2026. Applications must be in before 5 PM on the closing day.
Where can I check Runwal Enterprises IPO allotment status?▾
Runwal Enterprises IPO allotment is handled by MUFG Intime India Pvt.. You can check using your PAN or application number on the registrar's site once allotment is finalised.
Is Runwal Enterprises IPO a good investment?▾
We do not give buy or sell advice. What we can show you is evidence: how heavily this issue is actually being applied for, your realistic chance of getting shares, and what happened to past IPOs that looked like this one. Read those alongside the company's own financials and prospectus, and decide for yourself.
🛡️Regulatory Note: The grey market is not regulated by SEBI, NSE, or BSE. GMP data on ForgeUp is from informal sources for informational purposes only. ForgeUp.in does not facilitate or promote any grey market activity. Consult a SEBI-registered investment advisor before investing.
Important Disclaimer: Grey Market Premium (GMP) data on ForgeUp.in is sourced from grey market dealers and informal channels. Published for informational purposes only and does not constitute investment advice. GMP is not guaranteed to reflect actual listing prices. ForgeUp.in is not liable for investment decisions based on GMP data.